Clinical picture and treatment effects in 5 patients with Methylmalonic aciduria related to MMAA mutations
ConclusionsPatients with a mutation in the MMAA gene are sensitive to treatment with hydroxocobalamine, but the inclusion of appropriate treatment does not protect against neurodevelopmental disorders and chronic kidney disease.
Source: Molecular Genetics and Metabolism Reports - Category: Genetics & Stem Cells Source Type: research
More News: Brain | Chronic Kidney Disease | Genetics | Hypertension | Neurology | Rare Diseases | Renal Failure | Study | Urology & Nephrology | Vitamin B12 | Vitamins